Clinical Trials in Hubei, Hubei
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Solid Tumors
DualityBio Inc.492 enrolled37 locationsNCT06953089
Recruiting
Early Phase 1
This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis
Multiple Sclerosis
Daishi Tian15 enrolled1 locationNCT07303790